KC
WINT

Kepos Capital’s Windtree Therapeutics WINT Stock Holding History

Kepos Capital’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4
Closed -$188K – 570
2022
Q1 		$188K Hold
4
– – 0.01% 341
2021
Q4 		$265K Hold
4
– – 0.02% 370
2021
Q3 		$340K Hold
4
– – 0.02% 401
2021
Q2 		$378K Hold
4
– – 0.03% 334
2021
Q1 		$404K Buy
4
+2
+100% +$433K 0.03% 318
2020
Q4 		$462K Hold
2
– – 0.04% 244
2020
Q3 		$495K Hold
2
– – 0.05% 180
2020
Q2 		$630K Buy
+2
New +$634K 0.08% 131

Other funds holding WINT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RWM
Rockwood Wealth Management New Hope, Pennsylvania $1.58B AUM 19.24% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Kepos Capital's WINT Position: Q2 2022 in Review

Kepos Capital sold out of Windtree Therapeutics (WINT) in Q2 2022, closing a stake of 4 shares — an estimated $188K sold.

Kepos Capital first reported a position in WINT in Q2 2020 and held it in 8 quarters. The position peaked at $630K in Q2 2020. 10 funds tracked by Wall St. Rank hold WINT as of Q2 2022.

  • Kepos Capital reported no remaining Windtree Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Kepos Capital sold 4 Windtree Therapeutics shares in Q2 2022, an estimated $188K.
  • Kepos Capital first reported a position in Windtree Therapeutics in Q2 2020 and held it in 8 quarters.
  • Kepos Capital's Windtree Therapeutics position peaked at $630K in Q2 2020.
  • 10 funds tracked by Wall St. Rank held Windtree Therapeutics as of Q2 2022.

Based on Kepos Capital's 13F filing for Q2 2022, filed 12 Aug 2022.